Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › connective tissue disease

Connective tissue disease

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for connective tissue disease

3 trials tracked for connective tissue disease: 3 in phase 3 or 4 and 3 with published results. The most-cited published study has 167 citations.

3Trials tracked
3Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 1 Phase 3 2
  1. Phase 4 A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis Completed · 167 cited
  2. Phase 3 A Study of LY2127399 in Participants With Systemic Lupus Erythematosus Completed · 73 cited
  3. Phase 3 A Study of LY2127399 in Participants With Systemic Lupus Erythematosus Completed · 42 cited

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Case report and review: azacytidine plus ruxolitinib in connective tissue disease with CMML and myelofibrosis
Allergy & Immunology Sys. Review
Case report and review: azacytidine plus ruxolitinib in connective tissue disease with CMML and myelofibrosis A single patient found relief from blood cancer with a new drug combo
This case report and literature review describes a 52-year-old male with connective tissue disease, chronic myelomonocytic leukemia, and mye…
One man with blood cancer saw his fever and anemia improve after two years on a specific drug mix, offering a glimpse into potential new tre…
Frontiers May 14, 2026
Systematic review and meta-analysis of ENA seropositivity in ANA-IIF-negative connective tissue disease populations
Allergy & Immunology Meta-analysis
Systematic review and meta-analysis of ENA seropositivity in ANA-IIF-negative connective tissue disease populations A Negative ANA Test Can Still Miss Autoimmune Disease, Study Finds
This systematic review and meta-analysis evaluated the frequency of extractable nuclear antigen (ENA) seropositivity among 28,552 ANA-IIF-ne…
A negative ANA test doesn't always rule out autoimmune disease, with 14% of negative cases still showing other key antibodies.
Frontiers Apr 28, 2026